References
- Brodt H R, Kamps B S, Cute P, Knupp B, Staszevski S, Helm K B. Changing incidence of AIDS‐defining illnesses in the era of antiretroviral combination therapy. AIDS 1907; 11: 1731–1738
- Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987; 36(Supp l. 15)35–155
- Childs E A, Lyles R H, Seines Q A, Chen B, Miller E N, Cohen B A, Becker J T, Mellors J, McArthur J C. Plasma viral load and CD4 lymphocytes predict HIV‐associated dementia and sensory neuropathy. Neurology 1999; 52: 607–013
- Collier A, Marra C, Coombs R W. Cerebrospinal fluid (CSF) RNA levels in patients on chronic indinavir therapy (abstract 22). Abstracts of the Infectious Disease Society of America, 35th annual meeting. San Francisco Sept 13–16, 1997
- Concha M, Selnes O A, McArthur J C, Nancé-Sprson T, Updike M L, Royal W I I I, Soloman L, Vlahov D. Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users. Int J Addict 1995; 30: 823–841
- Condra J H, Emini E A. Preventing HIV‐1 drug resistance. Sci Med 1997; 4: 14–23
- Ferrando S, Rabkin J, Van Corp W, McElhiney M. Protease inhibitors are associated with less neuropsychological impairment with HIV infection. 5th Conference on Retroviruses and Opp ortunistic Infections, Abstract 186. Chicago, ILUSA 1998
- Hestad K, McArthur J H, Dal Pan C J, Seines O A, Nance‐Sproson T E, Aylward E, Mathews V P, McArthur J C. Regional brain atrophy in HIV‐1 infection: association with specific neuropsychological test performance. Acta Neurol Scund 1993; 88: 112–118
- Janssen R S, Cornblath D R, Epstein L C, Foa R P, McArthur J C, Price R W. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type‐1 (HIV‐1) infection. Report of a Working Croup of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41: 778–785
- Klove H. Clinical neuropsychology. The Medical Clinics of North America, F M Forster. W.B. Saunders, New York, NY 1962
- Le Tendre S, Ellis R, Heaton R K, Atkinson J H, McCutchan J A. Change in CSF RNA level correlate with the effects of maximal antirelroviral therapy on HIV associated cognitive disorder. 12th World AIDS Conference. Geneva 1998; 32198
- Matthews C G, Klove H. Instruction manual for the adult neuropsychology test battery. University of Wisconsin Medical School, Madison, WI 1964
- McArthur J C, Sacktor N C, Selnes O. HIV‐associated dementia. Sem Neurol 1999, (in press)
- Miller E N, Seines O A, McArthur J C, Satz P, Becker J T, Cohen B A, Sheridan K, Muchedo A M, Van Esorp W G, Visscher B. Neuropsychological performance in HIV‐1‐iniected homosexual men: The Multicenter AIDS Cohort Study (MACS). Neurology 1990; 40: 197–203
- Power C, Seines O A, Grim J A, McArthur J C. The HIV Dementia Scale: A rapid screeningtest. J AIDS 1995; 8: 273–278
- Reitan R. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271–276
- Sacktor N C, McArthur J C. Prospects for therapy of HIV‐associated neurologic disease. J Neurovirol 1997; 3: 89–101
- Sacktor N C, Lyles R H, Skolasky K L, Anderson D F, McArthur J C, McFarlane C, Seines O A, Becker J T, Cohen B, Wesch J, Miller E N. Combination antiretroviral therapy improves psychomotor speed performance in HIV+ homosexual men. Neurology 1999; 52: 1640–1647
- Seines O A, Jacobson L, Machado A M, Becker J T, Wesch J, Miller E N, Vischer B, McArthur J C. Normative data for a brief neuropsychological screening battery. Perceptual Motor Skills 1991; 73: 539–550
- Smith A. Symbol digit modalities test. Western Psychological Service, Los Angeles, GA 1982
- Van Gorp W G, Miller E N, Satz P, Visscher B. Neuropsychological performance in HIV‐1‐immunocompromised patients: a preliminary report. J Clin Exp Neuropsychol 1989; 11: 763–773